Relmada Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $200k | 42k | 4.83 |
| 2025-09-30 | $120k | 60k | 2.01 |
| 2025-06-30 | $108k | 181k | 0.60 |
| 2025-03-31 | $39k | 145k | 0.27 |
| 2024-12-31 | $112k | 215k | 0.52 |
| 2024-09-30 | $410k | 126k | 3.24 |
| 2024-06-30 | $386k | 129k | 3.00 |
| 2024-03-31 | $601k | 129k | 4.65 |
| 2023-12-31 | $521k | 126k | 4.14 |
| 2023-09-30 | $377k | 126k | 3.00 |
| 2023-06-30 | $238k | 99k | 2.40 |
| 2023-03-31 | $3.6k | 1.6k | 2.26 |
| 2022-12-31 | $21k | 5.9k | 3.49 |
| 2022-09-30 | $224k | 6.1k | 36.81 |
| 2022-06-30 | $25k | 1.3k | 18.83 |
| 2022-03-31 | $36k | 1.3k | 27.11 |
| 2021-12-31 | $72k | 3.2k | 22.59 |
| 2021-09-30 | $124k | 4.7k | 26.32 |
| 2021-06-30 | $147k | 4.6k | 31.86 |
| 2021-03-31 | $230k | 6.5k | 35.09 |
| 2020-12-31 | $238k | 7.4k | 32.07 |
| 2020-09-30 | $211k | 5.6k | 37.58 |
| 2020-06-30 | $374k | 8.4k | 44.73 |
| 2020-03-31 | $104k | 3.0k | 34.18 |
| 2019-12-31 | $167k | 4.3k | 39.15 |